Vertex Pharmaceuticals (VRTX) EBIT Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | -2,649.00 |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 30,461.00 |
| 10 | Incyte | 25.60 Bn | 21.07 Bn | 1.57 Bn | 2,139.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -377.00 |
| Mar 31, 2026 | 530.00 |
| Dec 31, 2025 | -708.00 |
| Sep 30, 2025 | -971.00 |
| Jun 30, 2025 | -1,155.00 |
| Mar 31, 2025 | -2,688.00 |
| Dec 31, 2024 | -711.00 |
| Sep 30, 2024 | -1,288.00 |
| Jun 30, 2024 | -13,074.00 |
| Mar 31, 2024 | -914.00 |
| Dec 31, 2023 | -655.00 |
| Sep 30, 2023 | -190.00 |
| Jun 30, 2023 | -593.00 |
| Mar 31, 2023 | -1,473.00 |
| Dec 31, 2022 | 586.00 |
| Sep 30, 2022 | 3,781.00 |
| Jun 30, 2022 | 2,169.00 |
| Mar 31, 2022 | 1,738.00 |
| Dec 31, 2021 | 2,767.00 |
| Sep 30, 2021 | 2,693.00 |